Vitamin D Supplements for Reducing Advanced Cancer Risk: Paulette Chandler, MD, MPH

In a study recently published in JAMA Network Open, a team of investigators led by Paulette Chandler, MD, MPH, found that vitamin D supplementation is associated with a decreased risk of developing advanced cancer, particularly among individuals with a normal body mass index (BMI). In this interview with i3 Health, Dr. Chandler, an Assistant Professor of Medicine at Harvard Medical School, discusses the significance of these results and the ongoing research investigating vitamin D supplementatio...
Continue reading

Vitamin D Supplements May Reduce the Risk of Developing Advanced Cancer

In individuals without cancer, vitamin D supplementation may decrease the risk of developing advanced cancer, especially for those with a normal body mass index (BMI), according to a recent analysis of a phase 3 trial. "Vitamin D may decrease tumor invasiveness and propensity to metastasize, leading to reduced cancer mortality," write the investigators, led by first author Paulette D. Chandler, MD, MPH, Assistant Professor of Medicine at Harvard Medical School. "Vitamin D may have a role in redu...
Continue reading

Lung Cancer Screening Adherence After Baseline Screening Is Lower Than Reported

Patients who undergo baseline lung cancer screening are less likely to adhere to screening recommendations compared with the screening rates of patients who participate in randomized clinical trials, according to a meta-analysis now published in JAMA Network Open. Undergoing regular cancer screening has been shown to reduce the risk of cancer mortality. Data from the 2018 National Health Interview Survey found that approximately 70% of eligible women underwent breast cancer screening within the ...
Continue reading

Cancer Overscreening in Older Adults: Jennifer L. Moss, PhD

According to a study recently published in JAMA Network Open, a high proportion of older adults with average cancer risk are overscreened for colorectal, cervical, and breast cancers after surpassing specified upper age limits recommended by the US Preventive Services Task Force (USPSTF). In this interview, Jennifer L. Moss, PhD, first author of the study, discusses the significance of these findings, explains the risks of overscreening, and shares advice for reducing overscreening among older a...
Continue reading

Thanks to COVID, New Cancer Diagnoses Fell by Nearly Half

During the COVID-19 pandemic, guidelines from the American Society of Clinical Oncology and other organizations have recommended that cancer screening procedures involving in-person visits, such as mammograms and colonoscopies, be postponed. These delays have contributed to a whopping 46.4% drop in the combined rate of new diagnoses for six cancers. This is the finding of a cross-sectional study, results of which have now been published in a research letter in JAMA Network Open, a...
Continue reading

Copyright © 2021 Oncology Data Advisor. All rights reserved.